Phosphorylation state and protein levels measured in BRAF(V600E/D) melanoma cell lines monitored by imaging - Dataset (ID:20219)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | 2nd Drug | Drug Concentration | Conc Unit | Time Point | Time Point Unit | Image | Measured Protein (Alexa Fluor 488) | Measured Protein Value (488) | Measured Protein (Alexa Fluor 568) | Measured Protein Value (568) | Measured Protein (Alexa Fluor 647) | Measured Protein Value (647) | Replicate | Plate Name | Plate Well |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0205 | uM | 24 | hr | p27 Kip1 | 458.83 | p-Rb(S807/S811) | 152.02 | p-ERK(T202/Y204) | 459.90 | 2 | Colo858-signal1 | G8 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0000 | uM | 24 | hr | p27 Kip1 | 447.88 | p-Rb(S807/S811) | 161.30 | p-ERK(T202/Y204) | 568.39 | 2 | Colo858-signal1 | G11 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.1280 | uM | 24 | hr | p27 Kip1 | 743.36 | p-Rb(S807/S811) | 68.92 | p-ERK(T202/Y204) | 51.05 | 2 | Colo858-signal1 | G6 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.3200 | uM | 24 | hr | p27 Kip1 | 983.23 | p-Rb(S807/S811) | 56.72 | p-ERK(T202/Y204) | 28.24 | 2 | Colo858-signal1 | G5 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0082 | uM | 24 | hr | p27 Kip1 | 461.45 | p-Rb(S807/S811) | 160.46 | p-ERK(T202/Y204) | 599.65 | 1 | Colo858-signal1 | F9 | |
Vemurafenib | COLO 858 | 2.0000 | uM | 24 | hr | p27 Kip1 | 1016.50 | p-Rb(S807/S811) | 42.64 | p-ERK(T202/Y204) | 14.04 | 1 | Colo858-signal1 | B3 | ||
JNK-IN-8 | COLO 858 | 0.3200 | uM | 24 | hr | p27 Kip1 | 445.16 | p-Rb(S807/S811) | 182.28 | p-ERK(T202/Y204) | 673.10 | 2 | Colo858-signal1 | E5 | ||
JNK-IN-8 | COLO 858 | 0.0082 | uM | 24 | hr | p27 Kip1 | 436.36 | p-Rb(S807/S811) | 155.67 | p-ERK(T202/Y204) | 648.15 | 1 | Colo858-signal1 | D9 | ||
JNK-IN-8 | COLO 858 | 0.3200 | uM | 24 | hr | p27 Kip1 | 453.72 | p-Rb(S807/S811) | 173.99 | p-ERK(T202/Y204) | 686.67 | 1 | Colo858-signal1 | D5 | ||
Vemurafenib | COLO 858 | 5.0000 | uM | 24 | hr | p27 Kip1 | 1100.60 | p-Rb(S807/S811) | 49.89 | p-ERK(T202/Y204) | 9.41 | 2 | Colo858-signal1 | C2 | ||
Vemurafenib | COLO 858 | 5.0000 | uM | 24 | hr | p-Histone H3(S10) | 265.46 | p-Rb(S807/S811) | 66.87 | p-S6(S235/S236 | 14.48 | 1 | Colo858-signal2 | B2 | ||
JNK-IN-8 | COLO 858 | 0.3200 | uM | 24 | hr | p-Histone H3(S10) | 367.65 | p-Rb(S807/S811) | 192.54 | p-S6(S235/S236 | 440.93 | 1 | Colo858-signal2 | D5 | ||
JNK-IN-8 | COLO 858 | 0.0000 | uM | 24 | hr | p-Histone H3(S10) | 357.02 | p-Rb(S807/S811) | 174.95 | p-S6(S235/S236 | 420.53 | 2 | Colo858-signal2 | E11 | ||
JNK-IN-8 | COLO 858 | 5.0000 | uM | 24 | hr | p-Histone H3(S10) | 315.08 | p-Rb(S807/S811) | 253.54 | p-S6(S235/S236 | 620.64 | 1 | Colo858-signal2 | D2 | ||
Vemurafenib | COLO 858 | 0.3200 | uM | 24 | hr | p-Histone H3(S10) | 150.91 | p-Rb(S807/S811) | 54.62 | p-S6(S235/S236 | 93.11 | 2 | Colo858-signal2 | C5 | ||
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0000 | uM | 24 | hr | p-Histone H3(S10) | 376.71 | p-Rb(S807/S811) | 165.48 | p-S6(S235/S236 | 397.13 | 2 | Colo858-signal2 | G11 | |
JNK-IN-8 | COLO 858 | 0.0512 | uM | 24 | hr | p-Histone H3(S10) | 302.14 | p-Rb(S807/S811) | 172.24 | p-S6(S235/S236 | 407.88 | 1 | Colo858-signal2 | D7 | ||
JNK-IN-8 | COLO 858 | 0.0205 | uM | 24 | hr | p-Histone H3(S10) | 288.25 | p-Rb(S807/S811) | 170.31 | p-S6(S235/S236 | 401.43 | 1 | Colo858-signal2 | D8 | ||
Vemurafenib | COLO 858 | 0.0082 | uM | 24 | hr | p-Histone H3(S10) | 341.90 | p-Rb(S807/S811) | 169.94 | p-S6(S235/S236 | 414.55 | 1 | Colo858-signal2 | B9 | ||
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0512 | uM | 24 | hr | p-Histone H3(S10) | 239.08 | p-Rb(S807/S811) | 140.42 | p-S6(S235/S236 | 380.85 | 2 | Colo858-signal2 | G7 | |
Vemurafenib | COLO 858 | 0.1280 | uM | 24 | hr | p-Histone H3(S10) | 204.59 | p-Rb(S807/S811) | 83.78 | p-S6(S235/S236 | 220.01 | 1 | Colo858-signal2 | B6 | ||
Vemurafenib | COLO 858 | 0.0082 | uM | 24 | hr | p-Histone H3(S10) | 301.75 | p-Rb(S807/S811) | 164.37 | p-S6(S235/S236 | 394.95 | 2 | Colo858-signal2 | C9 | ||
Vemurafenib | COLO 858 | 0.0512 | uM | 24 | hr | p-Histone H3(S10) | 284.31 | p-Rb(S807/S811) | 139.79 | p-S6(S235/S236 | 349.95 | 1 | Colo858-signal2 | B7 | ||
Vemurafenib | COLO 858 | JNK-IN-8 | 2.0000 | uM | 24 | hr | p-Histone H3(S10) | 271.62 | p-Rb(S807/S811) | 67.91 | p-S6(S235/S236 | 39.37 | 2 | Colo858-signal2 | G3 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.8000 | uM | 24 | hr | p-Histone H3(S10) | 164.14 | p-Rb(S807/S811) | 55.90 | p-S6(S235/S236 | 45.82 | 2 | Colo858-signal2 | G4 |